共 42 条
- [41] Transparency too little, too late? Why and how Health Canada should make clinical data and regulatory decision-making open to scrutiny in the face of COVID-19 JOURNAL OF LAW AND THE BIOSCIENCES, 2021, 7 (01):
- [42] Protein Data Bank in the Time of Coronavirus: How open-access 3D structures are enabling research and development in fundamental biology, biomedicine, biotechnology, and drug discovery as we confront the global SARS-CoV-2 pandemic ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2020, 76 : A47 - A47